Results 171 to 180 of about 1,909,115 (251)

Patch Testing in Individuals With Diabetes Using Medical Devices. Part 1-Contact Allergy to Baseline Series Allergens. [PDF]

Contact Dermatitis
Sukakul T, Ulriksdotter J, Mowitz M, Bruze M, Hamnerius N, Svedman C.   +5 more
europepmc   +1 more source

A Rare Case of Contact Allergy towards Impression Compound Material. [PDF]

Eur J Dent, 2021
Wan Ali WNS, Ahmad Tarmidzi NA.
europepmc   +1 more source

Unraveling the Multimodal Oncogenic Network of KITENIN: From Metabolic Reprogramming and Microenvironment Remodeling to Targeted Interventions

Cancer Nexus, EarlyView.
ABSTRACT KAI1 C‐terminal interacting tetraspanin (KITENIN) is an emerging oncogenic regulator associated with tumorigenesis, metastasis, therapeutic resistance, and poor clinical outcomes. Mechanistically, KITENIN promotes tumor cell proliferation, migration, invasion, and epithelial–mesenchymal transition (EMT) by activating oncogenic pathways ...
Niaz Mahmood Tanoy, Zarin Tasnim, Md Shiblee Sadik Sabuj, Tanvir Ahmed, Md Abdul Momin, Md Sadekuzzaman, Sumaia Islam Mow, Md Aktaruzzaman, Md Rashedunnabi Akanda   +8 more
wiley   +1 more source

Patch Testing in Individuals With Diabetes Using Medical Devices. Part 2-Contact Allergy to Medical Device Allergens and New Patch Test Recommendations. [PDF]

Contact Dermatitis
Ulriksdotter J, Mowitz M, Sukakul T, Bruze M, Hamnerius N, Svedman C.   +5 more
europepmc   +1 more source

Fragranced hand gels: beware the risk of contact allergy. [PDF]

Clin Exp Dermatol, 2021
Burden-Teh E, Shinhmar S, Bleiker T.
europepmc   +1 more source

Enhancing Evidence Generation by Linking Randomized Clinical Trials to Real‐World Data: The INVESTED‐Medicare Linkage Study

Clinical Pharmacology &Therapeutics, EarlyView.
Real‐world evidence (RWE) derived from real‐world data (RWD) can complement randomized controlled trials (RCTs), yet the validity of RWD relative to RCT data remains insufficiently characterized. We obtained post hoc consent and linked individual participant data from the US‐based INVESTED trial (2016–2019) with Medicare fee‐for‐service claims (2012 ...
Hanseul Cho, HoJin Shin, Mehdi Najafzadeh, Brian Claggett, Janinne Ortega‐Montiel, Jun Liu, Julie M. Paik, Narlina F. Lalani, Marie C. Bradley, John Concato, Scott D. Solomon, Orly Vardeny, Elisabetta Patorno   +12 more
wiley   +1 more source

Contact Allergy in Children in Europe: A Proposal for a Paediatric European Baseline Series. [PDF]

Contact Dermatitis
Simonsen AB, Rustemeyer T, Hadzavdic SL, Spiewak R, Fortina AB, Gonçalo M, Arnau AMG, Planella-Fontanillas N, Schuttelaar MLA, Dickel H, White J, Pónyai G, Wilkinson SM, Özkaya E, Dendooven E, Pustišek N, Johansen JD, Aerts O, European Baseline Series (EBS) Working Party of the European Society of Contact Dermatitis (ESCD).   +18 more
europepmc   +1 more source

How to Optimize Healthy Volunteer Screening and Enrolment in Clinical Trials: A Qualitative and Quantitative Approach to Evaluate Processes and Healthy Volunteers' Perceptions

Clinical Pharmacology &Therapeutics, EarlyView.
Healthy volunteers (HVs) are essential for phase I trials, yet their recruitment and screening remain resource‐intensive and ethically complex. High screening failure (SF) rates highlight the need to evaluate and understand all aspects of the enrolment processes. We analyzed SF patterns in a large German HV cohort and explored participants' motivations,
Evelyn Krohmer, Manuela König, Cathrin J. Vogt, Marina Streckebein, Sybille Baumann, Max Blumenstock, Ruwen Böhm, Fabian Müller, Nadja Struß, Viktoria S. Wurmbach, Antje Blank   +10 more
wiley   +1 more source

Patch Test Preparations: Basis and State-of-the-Art Modern Diagnostic Tools for Contact Allergy. [PDF]

J Clin Med
Zimmer J, Neimanis S, Schmidt S, Schubert S, Mahler V.   +4 more
europepmc   +1 more source

Contact Allergy to Ammonium Persulfate: An Epidemiologic Study of 2138 Consecutive Dermatitis Patients. [PDF]

Indian J Dermatol, 2021
Alajaji A, Scheinman P.
europepmc   +1 more source